Citation Impact
Citing Papers
Identification of a Primary Target of Thalidomide Teratogenicity
2010 StandoutScience
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences
2011
Multidrug Resistance-Associated Proteins: Expression and Function in the Central Nervous System
2006
Hallmarks of Cancer: The Next Generation
2011 Standout
Olanzapine in the Treatment of Refractory Migraine and Chronic Daily Headache
2002
Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies
2001 Standout
Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies
2008
ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood–brain barrier
2008
Animal models of human disease: zebrafish swim into view
2007 Standout
Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters
2016
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
2006 Standout
Nrf2-Keap1 signaling in oxidative and reductive stress
2018 Standout
Targeting Ferroptosis to Iron Out Cancer
2019 Standout
Structure and function of the blood–brain barrier
2009 Standout
Regulation of chromatin by histone modifications
2011 Standout
Glioblastoma and Other Malignant Gliomas
2013 Standout
Albumin–drug interaction and its clinical implication
2013 Standout
Design and development of polymers for gene delivery
2005 Standout
Cancer stem cells revisited
2017 Standout
Mesenchymal Stem Cells: Emerging Therapy for Duchenne Muscular Dystrophy
2009
NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches
2018 Standout
Clinically relevant drug interactions with antiepileptic drugs
2005
Air pollution: mechanisms of neuroinflammation and CNS disease
2009 Standout
A clinical study of 57 children with fetal anticonvulsant syndromes
2000
Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice
2003
Glioblastoma‐derived tumorospheres identify a population of tumor stem‐like cells with angiogenic potential and enhanced multidrug resistance phenotype
2006
Epigenetic treatment of solid tumours: a review of clinical trials
2015
Malignant Gliomas in Adults
2008 Standout
Light‐Controlled Histone Deacetylase (HDAC) Inhibitors: Towards Photopharmacological Chemotherapy
2015 StandoutNobel
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
The Glymphatic System: A Beginner’s Guide
2015 Standout
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
2007 Standout
Drug distribution in tumors: Mechanisms, role in drug resistance, and methods for modification
2007
Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs
2006 Nature
Advances in Duchenne muscular dystrophy gene therapy
2003
Tumours associated with BAP1 mutations
2012
Cisplatin: The first metal based anticancer drug
2019 Standout
Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism
2013 Standout
Herb-Drug Interactions
2005 Standout
Prevalence of Anti‐cardiolipin, Anti‐β2 Glycoprotein I, and Anti‐prothrombin Antibodies in Young Patients with Epilepsy
2002
Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring
2014 StandoutNobel
Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease
2009
Epigenetic opportunities and challenges in cancer
2009
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Drug Resistance and the Solid Tumor Microenvironment
2007 Standout
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
Management of glioblastoma: State of the art and future directions
2020 Standout
Headache, drugs and sleep
2014
Current Developments in Pt(IV) Prodrugs Conjugated with Bioactive Ligands
2018
Therapeutic implications of central and peripheral neurologic mechanisms in migraine
2003
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Autoinduction and steady‐state pharmacokinetics of carbamazepine and its major metabolites.
1992
Decreased plasma protein binding of valproate in patients with acute head trauma.
1994
Modulation of antigen‐presenting cells by HDAC inhibitors: implications in autoimmunity and cancer
2011
Fiber Types in Mammalian Skeletal Muscles
2011 Standout
Biology and Clinical Development of Vascular Endothelial Growth Factor–Targeted Therapy in Renal Cell Carcinoma
2004
Drug delivery and nanoparticles: Applications and hazards
2008 Standout
The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition
2014 Standout
Free Concentration of Carbamazepine and Carbamazepine-10,11-Epoxide in Children and Adults
1985
Thalidomide-induced antiangiogenic action is mediated by ceramide through depletion of VEGF receptors, and is antagonized by sphingosine-1-phosphate
2005
Angiogenesis
2006
Efficacy of anti-epileptic drugs in patients with gliomas and seizures
2009
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Membrane transporter proteins: a challenge for CNS drug development
2006
Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells
2010 StandoutNobel
Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection
2010
Works of D. Croci being referenced
Malformations in offspring of 305 epileptic women: a prospective study
2009
A phase I–II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma
2009
Changes in Unbound and Total Valproic Acid Concentrations After Replacement of Carbamazepine with Oxcarbazepine
1992
Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer
2003
Primary antiphospholipid syndrome (PAPS) and isolated partial seizures in adolescence. A case report
1994
Single-Dose Pharmacokinetics of Lamotrigine in Children: Influence of Age and Antiepileptic Comedication
2001
Expression of Drug Resistance Proteins Pgp, MRP1, MRP3, MRP5 AND GST-π in Human Glioma
2005
Effects of Thalidomide on Parameters Involved in Angiogenesis: An in vitro Study
2003
Changes in Primidone/Phenobarbitone Ratio During Pregnancy and the Puerperium
1984
Carbamazepine Plasma Levels in Children and Adults
1980
Plasma Levels of Primidone and Its Metabolite Phenobarbital
1983
The serotonergic agentm-chlorophenylpiperazine induces migraine attacks: A controlled study
2000